Company Overview - The company specializes in medical dressings, focusing on two main categories, with over 70% of revenue coming from Medline Group[1] - Medline is the largest global manufacturer and distributor of surgical supplies, with an IPO raising approximately $6.264 billion to enhance its market presence[1] Financial Performance - Revenue growth is projected to accelerate, with 2024 revenue expected to increase by 20.4% year-on-year, reaching approximately 6.92 billion yuan[1] - Net profit for 2024 is anticipated to grow by 20.5% year-on-year, reaching around 0.81 billion yuan[1] Market Trends - The global low-value consumables market is expected to grow at a CAGR of 8.3% from 2024 to 2031, driven by factors such as aging population and rising chronic disease rates[1] - The domestic market for low-value consumables is projected to reach approximately 1280 billion yuan in 2023, with a CAGR of 14.8% from 2018 to 2023[1] Internationalization Strategy - The company is in a deepening phase of internationalization, focusing on core customer strategies and expanding production capacity overseas[1] - Key international clients include Medline, Zarys, and Sejong Healthcare, with a strong emphasis on maintaining high customer loyalty and competitive pricing[1] Risks - The company faces risks related to dependency on a single customer, fluctuations in raw material prices, and potential market competition intensification[1]